X
Search
X

Patient Support Hotline

Call (844) 244-1309

ZERO360 is a free, comprehensive patient support service to help patients and their families navigate insurance and financial obstacles to cover treatment and other critical needs associated with cancer.

X

Subscribe to our E-Newsletter

Stay up-to-date on the latest news about prostate cancer. Join our distribution list to receive periodic email updates and our monthly e-newsletter.

  • Patient Support (844) 244-1309
  • Search
  • e-News Signup Enews Signup
  • Run/Walk
  • Donate

Prostate cancer organoids pave way towards precision oncology

Scientists develop organoid models of neuroendocrine prostate cancer to study EZH2 inhibitors and reveal a potential new target.

Researchers at the Georgia Institute of Technology, US, have developed research tools that shed new light on a currently untreatable form of prostate cancer, opening a pathway that may lead to novel therapeutics.

Read the full article here.

source: Anne Begley - Drug Target Review